Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 7, 2014; 20(29): 10050-10061
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.10050
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.10050
Figure 1 Distribution of IGF2 differentially methylated region 0 methylation levels in 351 serrated lesions.
Hyperplastic polyp, sessile serrated adenoma (SSA), SSA with cytological dysplasia, traditional serrated adenoma (TSA) and TSA with high-grade dysplasia (HGD) and 185 non-serrated adenomas (tubular adenoma, tubular adenoma with HGD, tubulovillous adenoma and tubulovillous adenoma with HGD). DMR: Differentially methylated region; IGF2: Insulin-like growth factor 2.
-
Citation: Naito T, Nosho K, Ito M, Igarashi H, Mitsuhashi K, Yoshii S, Aoki H, Nomura M, Sukawa Y, Yamamoto E, Adachi Y, Takahashi H, Hosokawa M, Fujita M, Takenouchi T, Maruyama R, Suzuki H, Baba Y, Imai K, Yamamoto H, Ogino S, Shinomura Y.
IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions. World J Gastroenterol 2014; 20(29): 10050-10061 - URL: https://www.wjgnet.com/1007-9327/full/v20/i29/10050.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i29.10050